NEW YORK (MarketWatch) -- Mylan Inc. received final approval from the Food and Drug Administration for its abbreviated drug application for Balsalazide Disodium Capsules to treat ulcerative colitis.

If you’re looking at treatment options for ulcerative colitis, you may want to learn more about balsalazide (Colazal). Balsalazide is a generic prescription drug that’s used to treat ulcerative ...

Balsalazide Disodium Capsules are the generic version of Salix Pharmaceuticals' Colazal (R) Capsules, which had U.S. sales of approximately $130.9 million for the 12 months ending Sept. 30, 2007. This ...

RALEIGH, N.C. -- Salix Pharmaceuticals today announced that the Company has received an approvable letter from the U.S. Food and Drug Administration (FDA) for balsalazide tablet studied as a treatment ...

Salix Pharmaceuticals and Eisai have entered into a multi-year co-promotion deal to promote Salix’s ulcerative colitis treatement Colazal (balsalazide disodium). Financial terms of the deal were not ...

Giazo, a UC Treatment for Male Patients The FDA has granted marketing approval for Giazo (balsalazide disodium; Salix) for the treatment of ulcerative colitis (UC) in male patients. A double-blind, ...

COLUMBUS, Ohio Roxane Laboratories has received approval from the Food and Drug Administration for a generic of Salix Pharmaceuticals anti-inflammatory drug Colazal. The drug is used to treat mild to ...

RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that it has submitted to the U.S. Food and Drug Administration (FDA) a New Drug Application (NDA) seeking ...

Mylan Inc. received final approval from the U.S. Food and Drug Administration to sell its balsalazide disodium capsules to treat ulcerative colitis, the company announced Monday. The drug company ...

RALEIGH, N.C. Salix Pharmaceuticals has received an approvable letter from the Food and Drug Administration for its ulcerative colitis drug Balsalazide Tablet NDA, the company announced May 16. The ...

Balsalazide Disodium Capsules are the generic version of SalixPharmaceuticals' Colazal (R) Capsules, which had U.S. sales of approximately$130.9 million for the 12 months ending Sept. 30, 2007.

Keir Starmer faces a big test on Thursday when voters in Manchester cast their ballots for a new lawmaker in an election polls say is too close to call between the British leader's Labour Party, ...